These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25991747)

  • 1. Relative contribution of morphine and morphine-6-glucuronide to the analgesic effect after morphine administration.
    Mikus G; Klimas R
    Br J Anaesth; 2015 Jun; 114(6):1007. PubMed ID: 25991747
    [No Abstract]   [Full Text] [Related]  

  • 2. Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide.
    Klimas R; Mikus G
    Br J Anaesth; 2014 Dec; 113(6):935-44. PubMed ID: 24985077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analgesic effect of morphine and its metabolites administered by an intracerebroventricular route].
    Serrié A
    Bull Acad Natl Med; 1995 Jun; 179(6):1237-52; discussion 1252-3. PubMed ID: 8542351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine is not a prodrug.
    Dahan A; Lötsch J
    Br J Anaesth; 2015 Jun; 114(6):1005-6. PubMed ID: 25991746
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics of morphine and its glucuronides after intravenous infusion of morphine and morphine-6-glucuronide in healthy volunteers.
    Lötsch J; Stockmann A; Kobal G; Brune K; Waibel R; Schmidt N; Geisslinger G
    Clin Pharmacol Ther; 1996 Sep; 60(3):316-25. PubMed ID: 8841154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition and analgesic effects of systemic morphine, morphine-6-glucuronide and normorphine in rat.
    Hasselström J; Svensson JO; Säwe J; Wiesenfeld-Hallin Z; Yue QY; Xu XJ
    Pharmacol Toxicol; 1996 Jul; 79(1):40-6. PubMed ID: 8841095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of morphine and morphine-6-glucuronide's pharmacokinetic-pharmacodynamic relationships in experimental and clinical pain.
    Sverrisdóttir E; Lund TM; Olesen AE; Drewes AM; Christrup LL; Kreilgaard M
    Eur J Pharm Sci; 2015 Jul; 74():45-62. PubMed ID: 25861720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of analgesic effect of morphine due to coadministration of rifampin.
    Fromm MF; Eckhardt K; Li S; Schänzle G; Hofmann U; Mikus G; Eichelbaum M
    Pain; 1997 Aug; 72(1-2):261-7. PubMed ID: 9272811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pharmacokinetic study of sublingual aerosolized morphine in healthy volunteers.
    Watson NW; Taylor KM; Joel SP; Slevin ML; Eden OB
    J Pharm Pharmacol; 1996 Dec; 48(12):1256-9. PubMed ID: 9004187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The bioavailability of morphine applied topically to cutaneous ulcers.
    Ribeiro MD; Joel SP; Zeppetella G
    J Pain Symptom Manage; 2004 May; 27(5):434-9. PubMed ID: 15120772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal absorption and stability of morphine 6-glucuronide in different physiological compartments of the rat.
    Stain-Texier F; Sandouk P; Scherrmann JM
    Drug Metab Dispos; 1998 May; 26(5):383-7. PubMed ID: 9571218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative measurement of spinal CSF microdialysate concentrations and concomitant antinociception of morphine and morphine-6beta-glucuronide in rats.
    Okura T; Komiyama N; Morita Y; Kimura M; Deguchi Y; Yamada S
    Life Sci; 2007 Mar; 80(14):1319-26. PubMed ID: 17258777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Morbid Obesity on the Pharmacokinetics of Morphine, Morphine-3-Glucuronide, and Morphine-6-Glucuronide.
    de Hoogd S; Välitalo PAJ; Dahan A; van Kralingen S; Coughtrie MMW; van Dongen EPA; van Ramshorst B; Knibbe CAJ
    Clin Pharmacokinet; 2017 Dec; 56(12):1577-1587. PubMed ID: 28510797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of analogues of M6G.
    Trécant C; Dlubala A; George P; Pichat P; Ripoche I; Troin Y
    Eur J Med Chem; 2011 Sep; 46(9):4035-41. PubMed ID: 21689868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Morphine poisoning in chronic kidney failure. Morphine-6-glucuronide as a pharmacologically active morphine metabolite].
    Dubs A; Wiedemeier P; Caduff B
    Dtsch Med Wochenschr; 1999 Jul; 124(30):896-8. PubMed ID: 10464491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine-6-glucuronide, an active morphine metabolite for the potential treatment of post-operative pain.
    Joshi GP
    Curr Opin Investig Drugs; 2008 Jul; 9(7):786-99. PubMed ID: 18600584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphine-3-glucuronide has a minor effect on morphine antinociception. Pharmacodynamic modeling.
    Gardmark M; Karlsson MO; Jonsson F; Hammarlund-Udenaes M
    J Pharm Sci; 1998 Jul; 87(7):813-20. PubMed ID: 9649348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of Morphine, Morphine-3-Glucuronide and Morphine-6-Glucuronide in Terminally Ill Adult Patients.
    Franken LG; Masman AD; de Winter BC; Koch BC; Baar FP; Tibboel D; van Gelder T; Mathot RA
    Clin Pharmacokinet; 2016 Jun; 55(6):697-709. PubMed ID: 26715216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of Morphine in Rats with Adjuvant-induced Arthritis.
    Kimura Y; Shibata M; Tamada M; Ozaki N; Arai K
    In Vivo; 2017; 31(5):811-817. PubMed ID: 28882946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized placebo-controlled trial of the activity of the morphine glucuronides.
    Penson RT; Joel SP; Bakhshi K; Clark SJ; Langford RM; Slevin ML
    Clin Pharmacol Ther; 2000 Dec; 68(6):667-76. PubMed ID: 11180027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.